Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2008
12/03/2008CN101316933A Method for concentrating, purifying and removing prion protein
12/03/2008CN101314786A Water-based collagen extracting process
12/03/2008CN101314772A Recombination expression and application of shrimp antimicrobial peptide genes in probiotic bacteria
12/03/2008CN101314767A Culture solution for reinforcing expression of fetal liver hemopoietic stem cell CD34 and preparation thereof
12/03/2008CN101314761A Pichia pastoris of high copy expression recombination hepatitis B surface antigen, preparation and application thereof
12/03/2008CN100439510C Process for preparing low molecular peptide and amino acid by biological enzymolysis of pig blood haematoglobin
12/03/2008CN100439490C Production of gamma-glutamyl cystein
12/03/2008CN100439399C Human antibodies that bind human IL-12 and methods for producing
12/03/2008CN100439398C Human monoclonal antibodies to dendritic cells
12/03/2008CN100439396C Polypeptide of ramification of ciliary nerves nutrilite for curing obesity
12/03/2008CN100439393C Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food
12/03/2008CN100439391C Process for producing hydrophobic polypeptides, proteins or peptides
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459534 Inactivation resistant factor VIII
12/02/2008US7459532 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders
12/02/2008US7459528 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors
12/02/2008US7459526 Method for synthesizing peptides, peptide mimetics and proteins
12/02/2008US7459525 Glycosylated protein for use in the treatment of blood disorders
12/02/2008US7459427 Reducing glucagon production by administering a corticotrophin releasing factor receptor 2 antagonist, especially a Urocortin III analog; treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety.
12/02/2008US7459310 DNA encoding protein of given amino acid sequence; culturing transformant comprising vector; screening for ligands; cancer and reproductive treatment
12/02/2008US7459308 Nucleic acid molecule encoding a CLASP-2 transmembrane protein
12/02/2008US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders
12/02/2008US7459299 Variant Humicola grisea CBH1.1
12/02/2008US7459298 Nucleic acid of given sequence; recombinant vectors; use in preparation of pharmaceutical kits
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459291 Chordin-like molecules and uses thereof
12/02/2008US7459290 Methods of using functional 30S subunits
12/02/2008US7459289 Nucleic acid encoding polypeptide having lactose permease activity; multidrug transporter; useful for modifying plants
12/02/2008US7459270 Which is incapable of reproduction within human cell lines; for treatment of human immunodeficency virus
12/02/2008US7459172 Drug encapsulation; hollow tubes; drug delivery
12/02/2008US7459165 isolated polypeptide consisting of the amino acid sequence set forth as SEQ ID NO:4 from which the signal peptide sequence set forth as SEQ ID NO:38 is deleted; Pseudomonas aeruginosa infection
12/02/2008US7459161 Methods for eliciting an immune response using cytolysin and hemolysin fusion proteins
12/02/2008US7459158 Can be used to vaccinate a mammal against specific self or non-self antigens
12/02/2008US7459157 Contacting human fluids with antibody directed against Minichromosome Maintenance protein 7 (MCM7 protein) and determining amount of binding; cytology
12/02/2008US7459143 Monoclonal antibodies; determination blood coagulation; dissolving clots; administering deimmunized immunointeractive molecules; using planar or computer assisted tomographic nuclear medicine scan to visualize a clot
12/02/2008CA2475116C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
12/02/2008CA2391961C Process for producing transglutaminase
12/02/2008CA2282841C A method of purifying factor viii/vwf-complex by means of cation exchange chromatography
12/02/2008CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide
12/02/2008CA2226400C Human complementarity determining region (cdr) - grafted antibody to ganglioside gm2
12/02/2008CA2205085C An in vitro system for determining formation of a.beta. amyloid
12/02/2008CA2152371C Dna amplification
12/02/2008CA2140538C Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
12/02/2008CA2131087C Streptomyces strains and methods for selectively producing a single streptogramin component
12/02/2008CA2120527C Helicobacter pylori genes necessary for the regulation and the maturation of urease and their use
12/01/2008CA2590593A1 Mutated hoxb4 proteins with improved stability, and methods of use thereof
11/2008
11/27/2008WO2008144753A2 Antibodies to tnf alpha and use thereof
11/27/2008WO2008144485A2 Inhibition of palmitoyl acyl transferase expression and/or activity for the regulation of antiproliferative factor activity
11/27/2008WO2008144484A1 Functional humanization of complementarity determining regions (cdrs)
11/27/2008WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008WO2008143892A1 Method of treating tuberculosis with interferons
11/27/2008WO2008143797A1 Methods of producing a secreted protein
11/27/2008WO2008143684A1 Methods of generation use of in vivo biotinylated recombinant antibodies
11/27/2008WO2008143513A1 Alg3 mutant
11/27/2008WO2008143199A1 Novel polypeptide, material for affinity chromatography, and method for separation and/or purification of immunoglobulin
11/27/2008WO2008142028A1 Method for producing a recombinant protein on a manufacturing scale
11/27/2008WO2008141795A2 Cell-free protein synthesis of deuterated proteins for structural and functional studies by nmr spectroscopy
11/27/2008WO2008045970A3 Compositions and methods of using chondroitinase abci mutants
11/27/2008WO2008027739A3 Antibodies to ntb-a
11/27/2008WO2008024769A3 Intensified perfusion production method
11/27/2008WO2008021367A3 Moenomycin biosynthesis-related compositions and methods of use thereof
11/27/2008WO2008005290A3 Methods for testing anti-thrombotic agents
11/27/2008WO2007133855A3 Glycoprotein synthesis and remodeling by enzymatic transglycosylation
11/27/2008WO2007130638A3 Production of sialylated n-glycans in lower eukaryotes
11/27/2008WO2007109324A3 Potent and selective nav 1.7 sodium channel blockers
11/27/2008WO2006091470A3 Improved halohydrin dehalogenases and related polynucleotides
11/27/2008WO2005116235A8 Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment
11/27/2008WO2005030981A3 Homogeneous populations of molecules
11/27/2008US20080295190 comprising a Cricetulus griseus ( FAIM, FADD, PDCD6 and Requiem) sequence capable of mediating apoptosis of cells
11/27/2008US20080293921 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue
11/27/2008US20080293917 Peptide Purification By Means Of Metal Ion Affinity Chromatography
11/27/2008US20080293636 Protein Constructs Designed for Targeting and Lysis of Cells
11/27/2008US20080293611 Polyol oxidases
11/27/2008US20080293106 Method For the Mass Production of Immunoglobulin Fc Region Deleted Initial Methionine Residues
11/27/2008US20080293105 Recombinant method for making multimeric proteins
11/27/2008US20080293104 Proteases and Methods for Producing Them
11/27/2008US20080293103 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
11/27/2008US20080293102 Compositions and methods for producing apolipoprotein
11/27/2008US20080293101 Engineered microorganisms for increasing product yield in biotransformations, related methods and systems
11/27/2008US20080293099 Lignan Glycosidase and Utilization of the Same
11/27/2008US20080293098 Dna Encoding Novel Enzyme Having D-Serine Synthase Activity, Method of Producing the Enzyme and Method of Producing D-Serine by Using the Same
11/27/2008US20080293077 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
11/27/2008US20080293068 Methods for engineering polypeptide variants via somatic hypermutation and polypeptide made thereby
11/27/2008US20080292753 Polypeptides Having Phytase Activity and Polynucleotides Encoding Same
11/27/2008US20080292704 Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins
11/27/2008US20080292662 Vaccine Comprising Recombinant Clpp Protein of Streptococcus Pneumoniae
11/27/2008US20080292658 Defective Influenza Virus Particles
11/27/2008US20080292652 Virus-Like Particles Comprising a Fusion Protein of the Coat Protein of Ap205 and an Antigenic Polypeptide
11/27/2008US20080292647 immunogenic protein in a biodrug, was encoded from an isolated host cell transfected with the recombinant expression vector; anticarcinogenic agent for treating skin cancer; vaccine for prevention and treatment; immunotherapy
11/27/2008US20080292641 Antigenic GM-CSF peptides and antibodies to GM-CSF
11/27/2008US20080292639 Humanized Anti-Amyloid Antibody
11/27/2008US20080292636 Chemokine panec-2 polynuleotides, polypeptides, antibodies and methods of making and using them
11/27/2008US20080292628 Chimeric Protein
11/27/2008US20080292620 PRLR-Specific Antibody and Uses Thereof
11/27/2008US20080292615 Diagnosis and treatment of disease
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292581 Interleukin-11 Fusion Proteins
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008CA2690825A1 Fusion molecules and il-15 variants
11/27/2008CA2688146A1 Antibodies to il-6 and use thereof
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 1125